SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bristol Myers Squibb Reports Preliminary Positive Alzheimer’s Psychosis Data

Bristol Myers Squibb said preliminary data from two late-stage studies showed its experimental treatment improved psychosis symptoms associated with Alzheimer’s disease.

BMY

Related stories